Contact Us | Print Page | Sign In | Register
News & Press
Filter news by category:

Read about recent events, essential information and the latest community news.

Displaying page 3 of 10
1  |  2  |  3  |  4  |  5  |  6  |  7  |  8  >   >>   >| 

Industry News for MS (INforMS)
Tuesday, March 7, 2017
CMSC INforMS: Horseback Riding Helps People w/Movement Disabilities, Review of 16 Studies Concludes »
Riding and other activities with horses can help adults and children with the balance, gait, and psychomotor disorders tha...
Wednesday, March 1, 2017
CMSC INforMS: People with MS Are Three-Six Times More Prone to Seizures Than Others, Study Reports »
People with multiple sclerosis (MS) are three to six times more likely to develop epilepsy than the general population, a...
Sunday, February 26, 2017
CMSC INforMS: Multiple sclerosis - New technology improves cognition »
Multiple sclerosis is a debilitating neurological disease that affects tens of thousands of Americans. While there is yet...
Thursday, February 23, 2017
CMSC INforMS: 11 Subtle Early Signs Of Multiple Sclerosis - The Sooner You Catch It The Better »
Multiple sclerosis is one of those scary health concerns that rarely comes up in conversation. And yet, learning about and...
Wednesday, February 15, 2017
CMSC INforMS: Stress and MS: Webinar from IOMSN Helps Manage Daily Stress »
When you live with multiple sclerosis, stress is unavoidable. Your first experience with the stress of MS is when you’re d...
Wednesday, February 8, 2017
CMSC INforMS: HackensackUMC opens multiple sclerosis center »
Hackensack University Medical Center has opened a new multiple sclerosis center. “We are very excited to offer a com...
Monday, February 6, 2017
CMSC INforMS: First blood biomarker for multiple sclerosis discovered »
Although there is no known cure for multiple sclerosis (MS), there are treatments that can help prevent new attacks and im...
Friday, February 3, 2017
CMSC INforMS: MS - New blood test can identify types of MS and if treatments are working »
Patients with multiple sclerosis will soon have access to a new test which can tell them exactly what type of MS they have...
Thursday, February 2, 2017
CMSC INforMS: Computer-assisted Therapy Found to Benefit MS Patients with Cognitive Difficulties »
Multiple sclerosis (MS) patients who are showing signs of cognitive impairment may benefit from computer-assisted cognitiv...
Monday, January 30, 2017
CMSC INforMS: Researchers Find Clues To Multiple Sclerosis In Blood »
In a new study led by Indian-American researchers at Brigham and Women’s Hospital, Harvard Medical School, suggests that m...
Monday, January 30, 2017
CMSC INforMS: Generic Form of Copaxone, GTR, Safe and Effective, Study Confirms »
An extension trial assessing generic glatiramer acetate (GTR) treatment in multiple sclerosis (MS) patients found that the...
Friday, January 27, 2017
CMSC INforMS: Sense of Smell Is Impaired in Half of Multiple Sclerosis Patients in Study »
Many multiple sclerosis (MS) patients have a reduced sense of smell, and the more relapses they have, the worse the proble...
Wednesday, January 25, 2017
CMSC INforMS: LiveWiseMS - A New Online Resource for People with MS »
There’s a new kid in town by the name of LiveWiseMS . Partnering with the International Organization of MS Nurses ( IOMSN...
Tuesday, January 24, 2017
CMSC INforMS: Epileptic Seizures in Multiple Sclerosis May Suggest Shared Pathology »
Patients with multiple sclerosis (MS) who experience seizures are more likely to be younger at the age of MS onset than pa...
Tuesday, January 17, 2017
CMSC INforMS: Grief, Self-preservation and Multiple Sclerosis »
Grief can weaken our immune system, elevate our blood pressure, and affect our overall health. During a loss, especially o...
Monday, January 9, 2017
CMSC INforMS: Template Improves Quality of Report on MRI for Multiple Sclerosis »
Use of a standardized template for reporting of brain magnetic resonance images (MRIs) in patients with multiple sclerosis...
Sunday, December 25, 2016
CMSC INforMS: Ocrelizumab Shown Effective Against Relapsing, Progressive Forms Of Multiple Sclerosis »
The drug ocrelizumab was found effective in the treatment of multiple sclerosis in three different large-scale, multi-cent...
Thursday, December 22, 2016
CMSC INforMS: 21st Century Cures Act Expected to Bring Real Change to MS Patients’ Lives »
President Obama’s signing of the 21st Century Cures Act on Dec. 13 is expected to bring real change to those living with m...
Saturday, December 10, 2016
CMSC INforMS: Multiple Sclerosis - Better Ways to Test Diet Changes »
Will a Mediterranean-style, non-dairy, low-carb diet improve symptoms for patients with multiple sclerosis (MS)? Helpin...
Thursday, December 8, 2016
CMSC INforMS: Imbalances in Brain Microbiota May Be Behind Demyelination in MS, Study Says »
Alterations in microorganisms in the brains of multiple sclerosis (MS) patients could contribute to underlying disease mec...
Tuesday, December 6, 2016
CMSC INforMS: Consortium of Multiple Sclerosis Centers Calls for Abstracts for 2017 Annual Meeting »
The Consortium of Multiple Sclerosis Centers (CMSC) is inviting researchers and healthcare professionals to submit abstr...
Monday, December 5, 2016
CMSC INforMS: Low Vitamin D Levels at Birth May Influence MS Risk in Adults, Study Suggests »
The risk of developing multiple sclerosis (MS) later in life may be higher for babies born with low levels of vitamin D ,...
Thursday, December 1, 2016
CMSC INforMS: ICER Releases Draft Report on Disease-modifying Therapies for MS, Welcomes Comment »
The Institute for Clinical and Economic Review ( ICER ) has released a Draft Evidence Report evaluating the comparative...
Tuesday, November 29, 2016
CMSC INforMS: UV Light May Lead Way to New Treatment for MS and Inflammation »
Researchers have found a way to harness inflammation with the help of ultraviolet (UV) light, making it possible to design...
Monday, November 21, 2016
CMSC INforMS: Acorda to Discontinue Dalfampridine for Treatment of Post-Stroke Walking Difficulties »
ARDSLEY, N.Y.--(BUSINESS WIRE)-- Acorda Therapeutics, Inc. (Nasdaq: ACOR ) today announced that the MILESTONE clinical stu...
Monday, November 14, 2016
CMSC INforMS: Genentech Results from Survey that shows Everyday Impact of Unpredictable MS Symptoms »
Jesse met his wife at a college dance. When they first started dating, she told him that she had multiple sclerosis (MS),...
Thursday, November 10, 2016
CMSC INforMS: Men & Women Seen to Differ in Genetic Susceptibility to MS & Its Progression in Study »
Researchers in Russia found for a first time an association between variants in GAL, a gene that codes for the galanin pro...
Monday, November 7, 2016
CMSC INforMS: Immune System May Harbor Natural Way of Fighting MS, Other Autoimmune Diseases »
A variant in the TYK2 gene, which encodes an immune system protein, may work to protect people from autoimmune disorders...
Wednesday, October 26, 2016
CMSC INforMS: Posture Difficulties in MS Linked to Areas of Nervous System Most Damaged by Disease »
Posture control is a complex skill, requiring different areas of the nervous system to work well and to work together — bu...
Monday, October 24, 2016
CMSC INforMS: ‘Rare’ Molecule in Immune System Is Common and May Be Part of What Goes Wrong in MS »
Researchers have discovered that a type of immune molecule — called “spliced epitopes,” once believed to be very rare &nbs...
Friday, October 14, 2016   (0 Comments - view/add)
CMSC INforMS: Selective Manipulation of Specific Receptors May Pave Way for New MS Therapies »
Mouse experiments with compounds having opposite actions on two receptors for TNF (tumor necrosis factor) — a key factor i...
Thursday, October 13, 2016   (0 Comments - view/add)
CMSC INforMS: Multiple Sclerosis Drug Could Reverse Physical Symptoms »
A drug that treats relapsing-remitting multiple sclerosis - a form of multiple sclerosis that accounts for around 85 perce...
Wednesday, October 12, 2016
CMSC INforMS: Multiple Sclerosis Research Finds Running 'Could Help Prevent' Notorious Disease »
For years, health advocates have urged the public to abandon their sedentary lifestyle and adopt a more active daily routi...
Monday, October 10, 2016
CMSC INforMS: Daclizumab approved (ZinbrytaTM) for relapsing forms of multiple sclerosis »
The DECIDE trial compared daclizumab 150mg subcutaneous injection every 4 weeks with interferon (INF) beta-1a (Avonex) 30m...
Friday, October 7, 2016
CMSC INforMS: Scientists develop system for early diagnosis of Parkinson's, MS, and Alzheimer's »
Virtual reality diagnosis using a new mathematical model linked to balance can detect first signs of these disorders, it i...

Displaying page 3 of 10
1  |  2  |  3  |  4  |  5  |  6  |  7  |  8  >   >>   >| 

The Consortium of Multiple Sclerosis Centers

3 University Plaza Drive, Suite 116 Hackensack, NJ 07601

Tel: 201.487.1050 | Fax: 862.772.7275